Ashish A. Deshmukh, PhD, MPH

Ashish DeshmukhAssistant Professor
aadeshmukh@phhp.ufl.edu
(352) 273-6064
HPNP, Room 3114

Ashish A. Deshmukh, PhD, MPH, is an Assistant Professor in the Department of Health Services Research, Management and Policy. Dr. Deshmukh is a clinical decision scientist and health economist. His research focuses on the development and evaluation of simulation models that have the potential to improve clinical decision-making and inform health policies. He is also interested in the design and analysis of economic evaluation studies using population-based observational data or as part of clinical trials.

His primary research application area is in epidemiology, prevention, and management of HPV-associated cancers. He also has a strong interest in evaluating cost-effectiveness of behavioral interventions targeted towards improving health outcomes. He has led articles in prestigious journals including Annals of Internal Medicine, Journal of the National Cancer Institute, Clinical Infectious Diseases, and Cancer.

Before joining the University of Florida, Dr. Deshmukh was a Janice Davis Gordon Memorial Postdoctoral Fellow in Clinical Decision Science at The University of Texas MD Anderson Cancer Center. During the fellowship, he was recipient of the Outstanding Postdoctoral Trainee in Cancer Prevention of 2016 award and The Thomas H. and Mayme P. Scott Endowed Fellowship in Cancer Research. His research on value of information analysis evaluating future HPV vaccination guidelines received the prestigious Lee Lusted Prize in Health Services, Outcomes and Policy Research at the 37th Annual Meeting of the Society for Medical Decision Making. Dr. Deshmukh received a Bachelor’s degree in Pharmacy from M.G.V.’s pharmacy college, India in 2007. He then pursued a Master’s degree in Health Policy and Management from Texas A&M School of Public Health (2010) and a Ph.D. in Public Health/Health Economics from The University of Texas Health Science Center School of Public Health at Houston (2014).

Full CV

Selected links of national media coverage

Publications 

  • Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T, Nyitray AG, Sikora A, Deshmukh AA. Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014.  Ann Intern Med[Online version]
  • Deshmukh AA, Chiao EY, Cantor SB, Stier EA, Goldstone SE, Nyitray AG, Wilkin T, Wang X, Chhatwal J. Management of precancerous anal intraepithelial lesions in HIV-positive MSM: clinical and cost-effectiveness. Cancer. 2017. [Online version]
  • Deshmukh AA, Cantor SB, Fenwick E, Chiao EY, Nyitray AG, Stier EA, Goldstone SE, Wilkin T, Chhatwal J. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now. Vaccine. 2017. 35: 5102-5019. [Online version]
  • Deshmukh AA, Shirvani S, Lal L, Swint JM, Cantor SB, Smith B, Likhacheva A. Cost-effectiveness analysis comparing conventional, hypofractionated, and intraoperative radiotherapy for early-stage breast cancer. J Natl Cancer Inst. 2017. 109 (11). DOI: 10.1093/jnci/djx068. [Online version]
  • Deshmukh AA, Tanner RJ, Luetke MC, Hong Y, Sonawane Deshmukh K, Mainous III AG. Prevalence and risk of penile HPV infection: Evidence from The National Health and Nutrition Examination Survey 2013-14. Clin Infect Dis. 2017; 64 (10):1360-1366. [Online version]
  • Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB. Clinical and economic evaluation of treatment strategies for T1N0 anal canal cancer. Am J Clin Oncol. 2016. [Online version]
  • Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Long-Term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men. Clin Infect Dis. 2015; 61(10): 1527-35. [Online version]
  • Deshmukh AA, Zhao H, Franzini L, Lairson D, Chiao EY, Swartz MD, Das P, Giordano S, Cantor SB. Total lifetime and cancer-related costs for elderly patients diagnosed with anal cancer in the United States. Am J Clin Oncol. 2015. [Online version]
  • Cantor SB, Deshmukh AA, Luca NS, Nogueras Gonzalez GM, Prokhorov AV. Cost-effectiveness analysis of smoking cessation training of physicians and pharmacists. Addictive Behaviors. DOI:10.1016/j.addbeh.2015.01.004. [Online version] 
  • Chen A, Jacobsen KH, Deshmukh AA, Cantor SB. The evolution of disability-adjusted life year (DALY). 2015. Socio-Economic Planning Sciences DOI: 10.1016/j.seps.2015.12.002.
  • Deshmukh AA, Chiao EY, Das P, Cantor SB. Cost-effectiveness analysis of vaccinating HIV-negative men who have sex with men in prevention of recurrent high-grade anal intraepithelial neoplasia. Vaccine. 2014. 32: 6941–6947. [Online version]
  • Chen A, Deshmukh AA, Richards-Kortum R, Molyneaux E, Kawaza K, Cantor SB. Cost-effectiveness of a neonatal bubble CPAP device in Malawi. BMC Pediatrics. 2014. DOI:10.1186/s12887-014-0288-1. [Online version]
  • Deshmukh AA, Cantor SB, Crosby MA, Shen Y, Wenli D, Bedrosian I, Peterson SK, Parker PA, Brewster AM. Cost of contralateral prophylactic mastectomy. Ann Surg Oncol. 2014. DOI 10.1245/s10434-014-3759-6. [Online version]
  • Lairson D, DiCarlo M, Deshmukh AA, Bittner-Fagan H, Sifri R, Katurakes N, Cocroft J, Andrel J, Swan H, Vernon SW, Myers RE. Cost-effectiveness of standard vs. a navigated intervention on colorectal cancer screening use in primary care. Cancer. 2014. [Online version] 
  • Cantor SB, Deshmukh AA, Krahn MD, Volk RJ. Use of forecasted assessment of quality of life to validate time-tradeoff utilities and a prostate cancer screening decision-analytic model. Health Expect. 2013. [Online version]
  • Kash B, Deshmukh AA. Developing a strategic marketing plan for physical and occupational therapy services: A collaborative project between a critical access hospital and a graduate program in healthcare management. Health Marketing Quarterly, 30:263–280, 2013. [Online version]
  • Begley CDeshmukh AAEschbach KFouladi NLiu QJReynolds T. Health insurance coverage in the Houston-Galveston area under the Patient Protection and Affordable Care Act. Tex Med. 2012; 108(11):e1. [Online version]